Pressemitteilung BoxID: 743079 (FINOX Biotech)
  • FINOX Biotech
  • Industrie Neuhof 23
  • 3422 Kirchberg

Finox Biotech announces FORWARD - a fertility research grant of EUR 1 million

(PresseBox) (Burgdorf, ) FINOX Biotech (Finox AG) announced today the FORWARD initiative. FORWARD (Finox Offers Research Work Award in Reproductive Development) is a EUR 1 million fertility research grant offered over the next five years for innovative research proposals in reproductive medicine. The grant is open to applications by any reproductive research institutions and IVF centres in Europe.

Over the next five years Finox Biotech will invest EUR 1 million in research grants for innovative research programmes to improve fertility treatments to the benefit of patients seeking to become parents. The grants will be awarded to the host institution, which will take on the management of the fund to support the research study.

Gavin Jelic-Masterton, CEO of Finox Biotech commented, "The initiation of the FORWARD programme demonstrates the commitment of Finox Biotech to the fertility area - through a combination of our long-term investment over five years and our desire to fund and be involved in innovative research programs to enable the further development of this therapeutic area for the benefit of patients seeking to become parents. Finox Biotech takes this commitment very seriously and by offering EUR 1 million over the next five years we will further strengthen our scientific stature in fertility."

The application closing date for the first round of funding is 15 November 2015. There will be a series of reviews following which shortlisted applicants will be notified by 30 January and given further details. The public announcement of winners will be made at ESHRE 2016 and the successful applicants will know the results by 30 March 2016.

For further information on FORWARD and how to apply, please contact or visit

FINOX Biotech

FINOX Biotech (FINOX AG) is a biopharmaceutical company with its corporate headquarters in Burgdorf, Switzerland. FINOX Biotech was founded in 2007 with a vision to become a leading company in the field of fertility therapies, by combining highquality Swiss medicines with innovative, award-winning delivery devices.

Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an